La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zoetis Bilan de santé
Santé financière contrôle des critères 4/6
Zoetis possède un total de capitaux propres de $5.0B et une dette totale de $6.6B, ce qui porte son ratio d'endettement à 132.9%. Son actif total et son passif total sont $14.2B et de $9.2B. L'EBIT de Zoetis est $3.2B ce qui fait que son ratio de couverture des intérêts 24.7. Elle dispose de liquidités et de placements à court terme de $1.6B.
Informations clés
132.9%
Ratio d'endettement
US$6.59b
Dette
| Ratio de couverture des intérêts | 24.7x |
| Argent liquide | US$1.57b |
| Fonds propres | US$4.96b |
| Total du passif | US$9.21b |
| Total des actifs | US$14.17b |
Mises à jour récentes de la santé financière
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jul 16
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Dec 06Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly
Sep 04These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well
Apr 16Is Zoetis (NYSE:ZTS) Using Too Much Debt?
Dec 29Recent updates
Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target
Aug 13Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)
Aug 07Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jul 16Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price
Jul 03Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader
Jun 11A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Jun 10Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth
May 23Zoetis: Why The Focus On Companion Animal Segment Will Pay Off
May 22The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 04Zoetis: Long-Term Buy Despite Safety Concerns
May 03Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
Apr 15Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit
Apr 12Zoetis: My Favorite Healthcare Stock Right Now
Mar 21Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)
Mar 03Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
Feb 27Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns
Jan 10Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E
Jan 01Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Dec 06Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today
Nov 18Zoetis: High-Quality Compounder With A Reasonable Price After Earnings
Nov 09Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now
Oct 26Zoetis Is An Impressive Healthcare Compounder
Sep 26Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Sep 25Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly
Sep 04Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.
Aug 22Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?
Aug 12Zoetis: My Dog Approves Of This Dividend Compounder
Jul 19Zoetis: A Purrfect Addition To Your Portfolio
Jun 22Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?
Jun 10These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well
Apr 16Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Mar 10Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus
Feb 14Zoetis Is An Awesome Dividend Growth Stock
Jan 17It's A Great Time To Buy Zoetis Shares
Jan 10Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's
Jan 03Is Zoetis (NYSE:ZTS) Using Too Much Debt?
Dec 29Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Zoetis raises quarterly dividend by 15.4% to $0.375/share
Dec 08Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)
Nov 20Zoetis' Q3 Earnings: Supply Issues Putting A Dent On Growth
Nov 08Analyse de la situation financière
Passif à court terme: Les actifs à court terme de ZTS ( $6.2B ) dépassent ses passifs à court terme ( $1.8B ).
Passif à long terme: Les actifs à court terme de ZTS ( $6.2B ) ne couvrent pas ses passifs à long terme ( $7.4B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de ZTS ( 101.2% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de ZTS a été réduit de 267.4% à 132.9% au cours des 5 dernières années.
Couverture de la dette: La dette de ZTS est bien couverte par le flux de trésorerie opérationnel ( 41.2% ).
Couverture des intérêts: Les paiements d'intérêts de ZTS sur sa dette sont bien couverts par l'EBIT ( 24.7 x couverture).